Back to IKT
BlackRock, Inc. IKT Position History
Inhibikase Therapeutics, Inc. • Healthcare
Quarters held
21
Latest value
$42K
Q3 2026
Peak value
$10.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $35K |
| Q4 2025 | $391K |
| Q4 2025 | $244K |
| Q4 2025 | $4.1M |
| Q4 2025 | $2M |
| Q1 2026 | $32K |
| Q1 2026 | $544K |
| Q1 2026 | $326K |
| Q1 2026 | $6M |
| Q1 2026 | $3.7M |
| Q2 2026 | $48K |
| Q2 2026 | $723K |
| Q2 2026 | $562K |
| Q2 2026 | $9.2M |
| Q2 2026 | $5.2M |
| Q3 2026 | $51K |
| Q3 2026 | $765K |
| Q3 2026 | $624K |
| Q3 2026 | $10.8M |
| Q3 2026 | $5.4M |
| Q3 2026 | $42K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $42K | 20.5K | — | — |
| Q3 2026 | $5.4M | 2.61M | — | — |
| Q3 2026 | $10.8M | 5.23M | — | — |
| Q3 2026 | $624K | 303.6K | — | — |
| Q3 2026 | $765K | 372.5K | — | — |
| Q3 2026 | $51K | 24.9K | — | — |
| Q2 2026 | $5.2M | 2.57M | — | — |
| Q2 2026 | $9.2M | 4.54M | — | — |
| Q2 2026 | $562K | 276.8K | — | — |
| Q2 2026 | $723K | 356.1K | — | — |
| Q2 2026 | $48K | 23.4K | — | — |
| Q1 2026 | $3.7M | 2.19M | — | — |
| Q1 2026 | $6M | 3.58M | — | — |
| Q1 2026 | $326K | 194.0K | — | — |
| Q1 2026 | $544K | 324.1K | — | — |
| Q1 2026 | $32K | 19.0K | — | — |
| Q4 2025 | $2M | 957.3K | — | — |
| Q4 2025 | $4.1M | 2.02M | — | — |
| Q4 2025 | $244K | 119.1K | — | — |
| Q4 2025 | $391K | 190.7K | — | — |
| Q4 2025 | $35K | 17.0K | — | — |